首页> 美国卫生研究院文献>BMC Complementary and Alternative Medicine >Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition
【2h】

Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition

机译:花tu再造丸通过改善突触可塑性和减少Aβ沉积来改善APP / PS1转基因小鼠的认知障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIt is well known that Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by memory deficits and cognitive decline. Amyloid-β (Aβ) deposition and synaptic dysfunction play important roles in the pathophysiology of Alzheimer’s disease (AD). The Huatuo Zaizao pill (HT) is a Traditional Chinese Medicine (TCM) that has been used clinically for many years in China, mainly for post-stroke rehabilitation and cognitive decline; however, the mechanism of cognitive function is not clear. In this study, we investigated the effect of HT on hippocampal synaptic function, Amyloid-β (Aβ) deposition in APP/PS1 AD transgenic mice.
机译:背景技术众所周知,阿尔茨海默氏病(AD)是一种进行性神经退行性疾病,其特征是记忆力不足和认知能力下降。淀粉样β(Aβ)沉积和突触功能障碍在阿尔茨海默氏病(AD)的病理生理中起重要作用。花tu再造丸(HT)是中药(TCM),已在中国临床使用多年,主要用于中风后康复和认知能力下降。但是,认知功能的机制尚不清楚。在这项研究中,我们调查了HT对APP / PS1 AD转基因小鼠海马突触功能,淀粉样β(Aβ)沉积的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号